Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IDXX.MX
BuyIDEXX Laboratories, Inc. · Healthcare · United States · $43.9B · Avg Vol: $21K/d
73
StockRankGet insider-trade alerts
Q
84
V
34
M
49
P/E (TTM)
39.2x
ROE
74.2%
D/E
0.7x
Dividend %
—
COMPANY DESCRIPTION
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
FINANCIAL SUMMARY (MXN)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.3B | 62.3B | 66.3B | 73.2B | 8.5% | 77.5B | 80.4B | 87.5B | 9.3% |
| EPS (MXN) | 138.16 | 173.05 | 183.25 | 224.09 | 17.5% | 241.64 | — | — | — |
| Shares | 82.9M | 83.0M | 81.6M | 79.7M | -3.8% | 78.8M | — | — | — |
| Debt | 25.0B | 18.2B | 16.8B | 16.6B | -12.8% | 18.7B | — | — | — |
| Equity | 10.4B | 25.3B | 27.1B | 27.3B | 38.2% | — | — | — | — |
| Op CF | 9.2B | 15.4B | 15.8B | 20.1B | 29.6% | 23.3B | — | — | — |
| Inv CF | -3.3B | -2.1B | -3.5B | -2.3B | — | — | — | — | — |
| Fin CF | -6.3B | -7.5B | -14.9B | -19.8B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-8.4%
SMA 50SMA 200
Close
$557.32
RSI (14)
0.0
52W High
$830.43
From 52W High
0.7%
SCORE BREAKDOWN
Quality
84
ROIC
66.4%99.4
ROE
74.2%98.4
GP/Assets
84.9%96.5
Op. Margin
35.0%94.1
FCF/Assets
36.9%98.6
Piotroski
894.4
Int. Cover
38.7x76.7
D/E Ratio
0.68x23.3
Current Ratio
1.17x16.4
Value
34
P/E (TTM)
39.2x27.2
EV/EBITDA
27.1x21.9
P/FCF
35.5x37.4
P/B
1.6x69.2
P/S
9.6x27.6
Div Yield
—N/A
Momentum
49
52W High %
67%44.0
RS 6M
-4%58.6
SMA 50/200
0.91x37.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
15%53.2
FUNDAMENTALS
Market Cap
$43.9B
P/E (Forward)
—
Gross Margin
62.4%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IDXX.MX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IDXX.MX | IDEXX Laboratories, Inc.(you) | $43.9B | 73 | Buy |
| A | Agilent Technologies, Inc. | $43.4B | 73 | Buy |
| IQV | IQVIA Holdings Inc. | $43.1B | 78 | Buy |
| ILMN | Illumina, Inc. | $32.6B | 78 | Buy |
| WAT | Waters Corporation | $40.7B | 63 | Hold |
| NTRA | Natera, Inc. | $47.0B | 56 | Hold |
| DGX | Quest Diagnostics Incorporated | $26.8B | 85 | Strong Buy |
| LH | Labcorp Holdings Inc. | $27.2B | 86 | Strong Buy |
| RVTY | Revvity, Inc. | $14.4B | 67 | Buy |
| DHR.MX | Danaher Corporation | $152.3B | 70 | Buy |
Peer medians: ROE -25.0% · P/E 29.6x · Gross margin 58.8%